Mastoparan, a Wasp Venom–Derived Peptide, Promotes Healing in <i>Candida albicans</i> –Infected Wounds through Antifungal and Anti-Inflammatory Mechanisms

BackgroundCandida albicans–infected wounds are difficult to treat due to delayed healing, excessive inflammation, and oxidative stress. Mastoparan, a bioactive peptide with antimicrobial and immunomodulatory properties, was investigated for its potential to enhance wound healing and antifungal activity. This study evaluated its effects on oxidative stress, inflammation, and the expression of TGF-β1, VEGF, NF-κB, and COL1A1 in a C. albicans–infected wound model, compared with ketoconazole.Materials and methodsThe antifungal activity of mastoparan was assessed in vitro using inhibition zone analysis and MIC determination against C. albicans. For comparison, ketoconazole was tested at 10 µg/mL in vitro and as a 2% topical formulation in vivo. In vivo wound healing was evaluated using two MIC-informed doses of mastoparan (7.8 and 15.6 mg/kg/day) administered topically once daily in non-infected and infected rat wound models, in comparison with ketoconazole. Eight groups were studied (n = 12/group): untreated control, wounded untreated, wounded + mastoparan (two doses), infected untreated, infected + mastoparan (two doses), and infected + ketoconazole (reference). Treatments were applied for 14 days. Wound healing, histology, ultrastructure, oxidative stress, inflammation, and gene expression analyzed.ResultsMastoparan showed strong antifungal activity and dose-dependently enhanced infected wound healing by accelerating wound closure, reducing fungal burden, improving tissue integrity, decreasing oxidative stress and inflammation, and promoting wound-healing–related gene expression, with the greatest effects observed at 15.6 mg/kg/day.ConclusionsMastoparan exerts potent antifungal activity and accelerates wound healing through coordinated antioxidant, anti-inflammatory, and pro-regenerative mechanisms, supporting its potential as a therapeutic alternative to conventional antifungal agents.

Authors

Institutions

Publication Details

Journal
Immunopharmacology and Immunotoxicology
Published
2026-07-22
DOI
https://doi.org/10.1080/08923973.2026.2705916
Primary Topic
Antimicrobial Peptides and Activities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mastoparan, a Wasp Venom–Derived Peptide, Promotes Healing in Candida albicans –Infected Wounds through Antifungal and Anti-Inflammatory Mechanisms

Alsayed E. Mekky, A A Elsharkawy, Dina M. Aboraya, Mohammed Yosri et al.
Immunopharmacology and Immunotoxicology
Antimicrobial Peptides and Activities
article

Mastoparan, a Wasp Venom–Derived Peptide, Promotes Healing in Candida albicans –Infected Wounds through Antifungal and Anti-Inflammatory Mechanisms

Alsayed E. Mekky, A A Elsharkawy, Dina M. Aboraya, Mohammed Yosri, Basma Amin, Eman El-Husseiny Helal, Hossam A. Abdelsamed, Rania A. Galhom, Asmaa Amer, Magda H. Rady
article en

Abstract

BackgroundCandida albicans–infected wounds are difficult to treat due to delayed healing, excessive inflammation, and oxidative stress. Mastoparan, a bioactive peptide with antimicrobial and immunomodulatory properties, was investigated for its potential to enhance wound healing and antifungal activity. This study evaluated its effects on oxidative stress, inflammation, and the expression of TGF-β1, VEGF, NF-κB, and COL1A1 in a C. albicans–infected wound model, compared with ketoconazole.Materials and methodsThe antifungal activity of mastoparan was assessed in vitro using inhibition zone analysis and MIC determination against C. albicans. For comparison, ketoconazole was tested at 10 µg/mL in vitro and as a 2% topical formulation in vivo. In vivo wound healing was evaluated using two MIC-informed doses of mastoparan (7.8 and 15.6 mg/kg/day) administered topically once daily in non-infected and infected rat wound models, in comparison with ketoconazole. Eight groups were studied (n = 12/group): untreated control, wounded untreated, wounded + mastoparan (two doses), infected untreated, infected + mastoparan (two doses), and infected + ketoconazole (reference). Treatments were applied for 14 days. Wound healing, histology, ultrastructure, oxidative stress, inflammation, and gene expression analyzed.ResultsMastoparan showed strong antifungal activity and dose-dependently enhanced infected wound healing by accelerating wound closure, reducing fungal burden, improving tissue integrity, decreasing oxidative stress and inflammation, and promoting wound-healing–related gene expression, with the greatest effects observed at 15.6 mg/kg/day.ConclusionsMastoparan exerts potent antifungal activity and accelerates wound healing through coordinated antioxidant, anti-inflammatory, and pro-regenerative mechanisms, supporting its potential as a therapeutic alternative to conventional antifungal agents.

Immunopharmacology and Immunotoxicology
Ain Shams University (EG), Suez Canal University (EG), Augusta University (US), Department of Embryology (US), Al-Azhar University (ID), International Islamic Center for Population Studies and Research (EG), Egyptian Russian University (EG)
Good health and well-being
Openalex Percentile: Top 10%
Antimicrobial Peptides and Activities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.